Our Experts

Testifying to New York City Council

Annice Kim, Ph.D. testified before the New York City Council regarding Mayor Bloomberg’s bill to ban the visible display of tobacco products.

Speaking to Media

Jen Uhrig, PhD, describes her work to understand the effectiveness of tailored text messages in encouraging HIV patients to take their medication on time.

Learn more »

Discussing Policy Implications for UAVs

Joe Eyerman, Ph.D., center, serves as part of a panel at an RTI-sponsored forum discussing policy issues concerning the use of domestic unmanned aerial vehicles.

Learn more »

Testifying to Congress

Josh Wiener, PhD, testified before Congress concerning long-term care to assist policy makers in making informed decisions.

Learn more »

Hosting Policy Forums

Jonathan Wald, PhD, speaks as a panelist for an RTI-hosted policy forum on engaging patients in Health IT. Our experts collaborate with stakeholders to explore a variety of pressing public policy challenges.

Learn more »

Briefing State Legislators

Doris Rouse, PhD, briefed state legislators on the role NC-based universities and nonprofits play in addressing global health issues.

Learn more »

We have leading experts in a wide variety of fields who are driven by the challenge of solving complex problems. As part of our effort to turn knowledge into practice, our experts testify before Congress, host policy forums to explore pressing challenges facing policy makers, and promote our research results to the media.



Experts in the News
Chief Scientist
"It seems to me that the best possible outcome at this point is for the FDA to regulate the crap out of e-cigarettes—in both senses of that coarse construction: regulate them heavily, and get the poisons, flavorings, and everything but nicotine out of them. And we desperately need clinical trials and observational studies to learn more about how e-cigarettes are being used and whether they are helpful in smoking cessation efforts."


Senior Developmental Epidemiologist
"It appears un-crushable OxyContin does put off a small number of users, specifically those that seem to use crushed OxyContin and heroin interchangeably. Take the effect to the overall population, however, and it's not significant."
Popular Science May, 2013

Upcoming Events